Activation of the Interleukin-6 Promoter by a Dominant Negative Mutant of C-Jun
Overview
Biophysics
Affiliations
The human IL-6 promoter contains multiple regulatory elements such as those binding transcription factors belonging to the NF-kappaB (-75/-63), C/EBP (-158/-145 and -87/-76) and AP-1 (-283/-277) families. Herein, we report that ectopic expression of c-Jun, C/EBPdelta, and the p65 subunit of NF-kappaB synergistically activates an IL-6 promoter construct containing only a TATA box and a kappaB binding site. These results suggest that interactions among NF-kappaB, C/EBP, and AP-1, which are all activated by the most powerful physiological inducers of the IL-6 gene, namely TNF-alpha and IL-1, may be crucial for maximal activation of the IL-6 promoter in response to the two cytokines. Furthermore, we show that a mutated form of c-Jun lacking the transactivation domain (TAM-67) was a much stronger activator of the IL-6 promoter than c-Jun. In combination with p65 and/or C/EBPdelta, TAM-67 also synergistically activated the IL-6 promoter, while it inhibited TNF-alpha induced AP-1 activity directing an AP-1-responsive reporter plasmid. Lastly, electrophoretic mobility shift assay (EMSA) results strongly suggest the formation of complexes between p65, C/EBPdelta, and/or c-Jun or TAM-67 on the kappaB site, supporting the idea that the functional synergism is determined by a physical interaction. These data provide new insight into the molecular mechanisms regulating the formation of the transcription complex responsible for IL-6 promoter activation.
Kitzberger C, Shehzad K, Morath V, Spellerberg R, Ranke J, Steiger K Mol Ther Oncolytics. 2023; 30:238-253.
PMID: 37701849 PMC: 10493263. DOI: 10.1016/j.omto.2023.08.004.
TLR5-Derived, TIR-Interacting Decoy Peptides to Inhibit TLR Signaling.
Javmen A, Zou J, Nallar S, Szmacinski H, Lakowicz J, Gewirtz A J Immunol. 2023; 210(9):1419-1427.
PMID: 36946775 PMC: 10121880. DOI: 10.4049/jimmunol.2200394.
Bertran L, Eigbefoh-Addeh A, Portillo-Carrasquer M, Barrientos-Riosalido A, Binetti J, Aguilar C Biomedicines. 2022; 10(6).
PMID: 35740337 PMC: 9219880. DOI: 10.3390/biomedicines10061315.
ERK5 modulates IL-6 secretion and contributes to tumor-induced immune suppression.
Riegel K, Yurugi H, Schloder J, Jonuleit H, Kaulich M, Kirschner F Cell Death Dis. 2021; 12(11):969.
PMID: 34671021 PMC: 8528934. DOI: 10.1038/s41419-021-04257-8.
Inflammatory Amplification: A Central Tenet of Uterine Transition for Labor.
Leimert K, Xu W, Princ M, Chemtob S, Olson D Front Cell Infect Microbiol. 2021; 11:660983.
PMID: 34490133 PMC: 8417473. DOI: 10.3389/fcimb.2021.660983.